322 related articles for article (PubMed ID: 31339457)
1. Intra-host emergence of an enterovirus A71 variant with enhanced PSGL1 usage and neurovirulence.
Sun L; Tijsma A; Mirabelli C; Baggen J; Wahedi M; Franco D; De Palma A; Leyssen P; Verbeken E; van Kuppeveld FJM; Neyts J; Thibaut HJ
Emerg Microbes Infect; 2019; 8(1):1076-1085. PubMed ID: 31339457
[TBL] [Abstract][Full Text] [Related]
2. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice.
Tee HK; Tan CW; Yogarajah T; Lee MHP; Chai HJ; Hanapi NA; Yusof SR; Ong KC; Lee VS; Sam IC; Chan YF
PLoS Pathog; 2019 Nov; 15(11):e1007863. PubMed ID: 31730673
[TBL] [Abstract][Full Text] [Related]
3. Enterovirus A71 Induces Neurological Diseases and Dynamic Variants in Oral Infection of Human SCARB2-Transgenic Weaned Mice.
Lin JY; Weng KF; Chang CK; Gong YN; Huang GJ; Lee HL; Chen YC; Huang CC; Lu JY; Huang PN; Chiang HJ; Chen CM; Shih SR
J Virol; 2021 Oct; 95(21):e0089721. PubMed ID: 34379497
[TBL] [Abstract][Full Text] [Related]
4. Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors.
Hsieh CF; Jheng JR; Lin GH; Chen YL; Ho JY; Liu CJ; Hsu KY; Chen YS; Chan YF; Yu HM; Hsieh PW; Chern JH; Horng JT
Emerg Microbes Infect; 2020 Dec; 9(1):1194-1205. PubMed ID: 32397909
[TBL] [Abstract][Full Text] [Related]
5. Enterovirus A71 VP1 Variation A289T Decreases the Central Nervous System Infectivity via Attenuation of Interactions between VP1 and Vimentin In Vitro and In Vivo.
Zhu H; Cao Y; Su W; Huang S; Lu W; Zhou Y; Gao J; Zhao W; Zhang B; Wu X
Viruses; 2019 May; 11(5):. PubMed ID: 31121933
[TBL] [Abstract][Full Text] [Related]
6. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans.
Huang SW; Huang YH; Tsai HP; Kuo PH; Wang SM; Liu CC; Wang JR
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931688
[TBL] [Abstract][Full Text] [Related]
7. Clinically isolated enterovirus A71 subgenogroup C4 strain with lethal pathogenicity in 14-day-old mice and the application as an EV-A71 mouse infection model.
Xu Y; Ma S; Zhu L; Huang Z; Chen L; Xu Y; Yin H; Peng T; Wang Y
Antiviral Res; 2017 Jan; 137():67-75. PubMed ID: 27864074
[TBL] [Abstract][Full Text] [Related]
8. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
9. Cellular receptors for enterovirus A71.
Kobayashi K; Koike S
J Biomed Sci; 2020 Jan; 27(1):23. PubMed ID: 31924205
[TBL] [Abstract][Full Text] [Related]
10. Adaptation and Virulence of Enterovirus-A71.
Kobayashi K; Koike S
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452525
[TBL] [Abstract][Full Text] [Related]
11. Enterovirus A71 Infection Activates Human Immune Responses and Induces Pathological Changes in Humanized Mice.
Ke Y; Liu WN; Her Z; Liu M; Tan SY; Tan YW; Chan XY; Fan Y; Huang EK; Chen H; En Chang KT; Chan JKY; Hann Chu JJ; Chen Q
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429352
[TBL] [Abstract][Full Text] [Related]
12. Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid.
Sun L; Lee H; Thibaut HJ; Lanko K; Rivero-Buceta E; Bator C; Martinez-Gualda B; Dallmeier K; Delang L; Leyssen P; Gago F; San-Félix A; Hafenstein S; Mirabelli C; Neyts J
PLoS Pathog; 2019 May; 15(5):e1007760. PubMed ID: 31071193
[TBL] [Abstract][Full Text] [Related]
13. Severity of enterovirus A71 infection in a human SCARB2 knock-in mouse model is dependent on infectious strain and route.
Zhu J; Chen N; Zhou S; Zheng K; Sun L; Zhang Y; Cao L; Zhang X; Xiang Q; Chen Z; Wang C; Fan C; He Q
Emerg Microbes Infect; 2018 Dec; 7(1):205. PubMed ID: 30518755
[TBL] [Abstract][Full Text] [Related]
14. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
Meng T; Wong SM; Chua KB
J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
[TBL] [Abstract][Full Text] [Related]
15. A clinically authentic mouse model of enterovirus 71 (EV-A71)-induced neurogenic pulmonary oedema.
Victorio CB; Xu Y; Ng Q; Chua BH; Alonso S; Chow VT; Chua KB
Sci Rep; 2016 Jun; 6():28876. PubMed ID: 27357918
[TBL] [Abstract][Full Text] [Related]
16. Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products.
Li G; Gao Q; Yuan S; Wang L; Altmeyer R; Lan K; Yin F; Zou G
Antiviral Res; 2017 Jul; 143():85-96. PubMed ID: 28412182
[TBL] [Abstract][Full Text] [Related]
17. Enterovirus A71: virulence, antigenicity, and genetic evolution over the years.
Huang SW; Cheng D; Wang JR
J Biomed Sci; 2019 Oct; 26(1):81. PubMed ID: 31630680
[TBL] [Abstract][Full Text] [Related]
18. Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses.
Ong KC; Wong KT
Brain Pathol; 2015 Sep; 25(5):614-24. PubMed ID: 26276025
[TBL] [Abstract][Full Text] [Related]
19. The internal ribosome entry site determines the neurotropic potential of enterovirus A71.
Wu GH; Lee KM; Kao CY; Shih SR
Microbes Infect; 2023 Jun; 25(5):105107. PubMed ID: 36708870
[TBL] [Abstract][Full Text] [Related]
20. Contemporary Circulating Enterovirus D68 Strains Have Acquired the Capacity for Viral Entry and Replication in Human Neuronal Cells.
Brown DM; Hixon AM; Oldfield LM; Zhang Y; Novotny M; Wang W; Das SR; Shabman RS; Tyler KL; Scheuermann RH
mBio; 2018 Oct; 9(5):. PubMed ID: 30327438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
